Los Angeles (July 22, 2019) – Good Samaritan Hospital is among the
first hospitals in Los Angeles to offer the LOTUS Edge™ Valve System
to high-risk patients with severe aortic stenosis.
As a non-surgical alternative for these patients, often with complex anatomical
challenges, the transcatheter aortic valve replacement (TAVR) device is
delivered via a minimally-invasive procedure to restore proper valve function.
The Boston Scientific LOTUS Edge device is the only aortic valve approved
by the U.S. Food and Drug Administration that is 100 percent repositionable,
which enables physicians to precisely place the new valve into an optimal
position in the heart; thereby helping to improve outcomes for the patient.
And because not everyone’s valve is the same size, the device also
features a braided valve frame and an adaptive seal that minimizes paravalvular
regurgitation or leaking (PVL) by conforming to the patient’s native
Aortic valve stenosis affects seven percent of all people over the age
of 65.1. The only effective treatment is to replace the aortic valve.
Left untreated, severe aortic stenosis can eventually lead to heart failure,
severe infection and even sudden death.